Nothing Special   »   [go: up one dir, main page]

NO20032156L - Treatment of anxiety disorders - Google Patents

Treatment of anxiety disorders

Info

Publication number
NO20032156L
NO20032156L NO20032156A NO20032156A NO20032156L NO 20032156 L NO20032156 L NO 20032156L NO 20032156 A NO20032156 A NO 20032156A NO 20032156 A NO20032156 A NO 20032156A NO 20032156 L NO20032156 L NO 20032156L
Authority
NO
Norway
Prior art keywords
treatment
anxiety disorders
anxiety
disorders
Prior art date
Application number
NO20032156A
Other languages
Norwegian (no)
Other versions
NO20032156D0 (en
Inventor
Holly Read Thomasson
David Michelson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20032156D0 publication Critical patent/NO20032156D0/en
Publication of NO20032156L publication Critical patent/NO20032156L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20032156A 2000-11-15 2003-05-13 Treatment of anxiety disorders NO20032156L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24901000P 2000-11-15 2000-11-15
US26536201P 2001-01-31 2001-01-31
PCT/US2001/027801 WO2002040006A2 (en) 2000-11-15 2001-11-06 Treatment of anxiety disorders

Publications (2)

Publication Number Publication Date
NO20032156D0 NO20032156D0 (en) 2003-05-13
NO20032156L true NO20032156L (en) 2003-05-13

Family

ID=26939750

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032156A NO20032156L (en) 2000-11-15 2003-05-13 Treatment of anxiety disorders

Country Status (16)

Country Link
EP (1) EP1395253A2 (en)
JP (1) JP2004529073A (en)
KR (1) KR20030051812A (en)
CN (1) CN1822825A (en)
AU (1) AU2002217757A1 (en)
BR (1) BR0115301A (en)
CA (1) CA2426069A1 (en)
CZ (1) CZ20031339A3 (en)
EA (1) EA200300567A1 (en)
HR (1) HRP20030384A2 (en)
IL (1) IL155874A0 (en)
MX (1) MXPA03004190A (en)
NO (1) NO20032156L (en)
PL (1) PL366119A1 (en)
SK (1) SK5422003A3 (en)
WO (1) WO2002040006A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004525912A (en) * 2001-03-06 2004-08-26 イーライ・リリー・アンド・カンパニー Inhibitors of monoamine uptake
US20040092519A1 (en) * 2002-08-14 2004-05-13 Fred Hassan New treatment for hot flashes
GB0309440D0 (en) * 2003-04-25 2003-06-04 Lilly Co Eli Quinolone derivatives
WO2004103356A2 (en) * 2003-05-15 2004-12-02 Eli Lilly And Company Treatment of emotional dysregulation
CN1889940A (en) * 2003-12-12 2007-01-03 伊莱利利公司 Treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
US8440724B2 (en) 2008-01-09 2013-05-14 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US20120220665A1 (en) * 2009-11-03 2012-08-30 Mayo Foundation For Medical Education And Research Inhibiting Neurotransmitter Reuptake
WO2011056788A2 (en) * 2009-11-03 2011-05-12 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US9944618B2 (en) 2013-03-14 2018-04-17 Mayo Foundation For Medical Education And Research Inhibiting neurotransmitter reuptake
US11446268B2 (en) * 2019-02-01 2022-09-20 Yamo Pharmaceuticals Llc Compositions and methods for treating anxiety-related disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2931997A (en) * 1996-05-07 1997-11-26 Merck & Co., Inc. Treatment of mood disorders with a growth hormone secretagogue
IT1305322B1 (en) * 1998-04-23 2001-05-04 Pharmacia & Upjohn Spa Use of reboxetine for treating obsessive compulsive disorder and panic disorder
KR100948757B1 (en) * 1999-07-01 2010-03-23 파마시아 앤드 업존 캄파니 엘엘씨 Highly Selective Norepinephrine Reuptake Inhibitors and Methods of Using the Same

Also Published As

Publication number Publication date
EP1395253A2 (en) 2004-03-10
NO20032156D0 (en) 2003-05-13
AU2002217757A1 (en) 2002-05-27
CZ20031339A3 (en) 2003-10-15
JP2004529073A (en) 2004-09-24
PL366119A1 (en) 2005-01-24
HRP20030384A2 (en) 2003-08-31
CA2426069A1 (en) 2002-05-23
SK5422003A3 (en) 2003-12-02
WO2002040006A2 (en) 2002-05-23
CN1822825A (en) 2006-08-23
BR0115301A (en) 2004-12-14
IL155874A0 (en) 2003-12-23
MXPA03004190A (en) 2003-09-22
EA200300567A1 (en) 2004-10-28
WO2002040006A3 (en) 2003-12-24
KR20030051812A (en) 2003-06-25

Similar Documents

Publication Publication Date Title
NO20040097L (en) Combinations for the treatment of inflammatory disorders
NO20024273L (en) Therapeutic uses of PPAR mediators
NO20031442L (en) Morpholine-acetamide derivatives for the treatment of inflammatory diseases
GB0007193D0 (en) Treatment of movrmrnt disorders
NO20026263L (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
NO20031443D0 (en) Compounds useful for the treatment of inflammatory diseases
NO20041386L (en) Combinations for the treatment of immuno-inflammatory disorders
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024486L (en) Improved treatment of neovascularization
NO20020062L (en) Treatment of neurotic disorders
DE60236743D1 (en) FOR THE TREATMENT OF ANDROGEN-DEPENDENT DISEASES
NO20032156L (en) Treatment of anxiety disorders
NO20023425D0 (en) Procedures for relieving anxiety
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
NO20026219L (en) Compounds for the treatment of impaired fundic relaxation
NO20024776L (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20024777L (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024236D0 (en) Treatment of psoriasis
NO20023803D0 (en) Use of mirtazapine for the treatment of sleep disorders
NO20010390D0 (en) Treatment of anxiety disorders
DK1309322T3 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
NO20030717L (en) Compounds for the treatment of addiction disorders
EE200200670A (en) S-methyldihydroziprasidone for the treatment of psychiatric and ocular disorders
NO20024331D0 (en) Treatment of disorders related to the serotonergic system
NO20030767D0 (en) Treatment of burns

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application